After treating ccRCC cells stably overexpressing CYP1B1 and SU-R ccRCC cells with CYP1B1 knockdown with CHX, we observed significant changes in HIF2α protein stability. Here, CYP1B1 is linked to nonpapillary renal cell carcinoma.